Market Place
Sourcing Support
All News #Library
Biotech
Excision Bio Reports Positive Preclinical Data in HBV EBT-107
15 Sep 2025 //
GLOBENEWSWIRE
Excision BioTherapeutics Highlights EBT-107 for Hepatitis B
15 May 2025 //
GLOBENEWSWIRE
Excision BioTherapeutics Presents Data at ASGCT 2025 Meeting
13 May 2025 //
GLOBENEWSWIRE
Excision BioTherapeutics Presents at Genome Editing Summit
03 Dec 2024 //
GLOBENEWSWIRE
EBT-107 Shows Antiviral Activity As Potential HBV Therapy
16 Sep 2024 //
GLOBENEWSWIRE
Excision BioTherapeutics Announces Oral Presentation
09 Sep 2024 //
GLOBENEWSWIRE
Excision BioTherapeutics Publishes EBT-104 Data For HSV-1 Keratitis Treatment
14 Aug 2024 //
GLOBENEWSWIRE
Excision Announces EBT-101 Data In HIV, Efficacy In Herpes, Hepatitis B
13 May 2024 //
GLOBENEWSWIRE
Excision’ attempt to gene edit HIV disappointsThe companyrevamp vector: #ASGCT24
10 May 2024 //
ENDPTS
Excision Bio HSV-1 Keratitis Data At CRISPRMED24 April 24
22 Apr 2024 //
GLOBENEWSWIRE
Excision Bio`s HBV EBT-107 Positive Data Oral At ASGCT 2024
22 Apr 2024 //
GLOBENEWSWIRE
Excision Bio`s Positive HSV-1 Keratitis EBT-104 Data At ASGCT
22 Apr 2024 //
GLOBENEWSWIRE
Excision BioTherapeutics Presents HSV-1 Keratitis Data at CRISPRMED24
16 Apr 2024 //
GLOBENEWSWIRE
Excision Presents Clinical Data from Ongoing Phase 1/2 Trial of EBT-101
25 Oct 2023 //
GLOBENEWSWIRE
Excision Announces Presentation of Interim Clinical Data for EBT-101
19 Oct 2023 //
GLOBENEWSWIRE
Excision Announces Publication of Data Supporting CRISPR-Based Gene Therapy
17 Aug 2023 //
GLOBENEWSWIRE
Excision BioTherapeutics Receives FDA Fast Track Designation for EBT-101
20 Jul 2023 //
GLOBENEWSWIRE
Excision Appoints Jeffrey B. Kindler to its Board of Directors
01 Jun 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.